chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received 1st Pfizer vaccination on 3/24/21 at 2:50 PM in left arm at college campus where I am employed ( - ).  No pain or rash whatsoever. On Saturday 3/27,21, almost 4 days later, at about 1:00 PM, felt hives breaking out on my sides.  It traveled up to my lower armpits, but never went into my arm areas.  Later that day, it traveled down side of legs, but then dissipated.  I went to bed about 9:30 PM that night with only slight discomfort. At 1:30 AM on Sunday 3/28/21, I awoke with severely swollen lips and face.  My breathing began to get difficult, so I immediately headed to the ER at  (about 30 minutes away). They at first started to give me a dose of Benedryl, but I explained to them that I am allergic to it.  I then instead received some Prednisone and immediately the swelling subsided.  Dr.  prescribed 15 pills over a 5-day span to totally clear up the reaction.
Breakthrough case admission after 5 vaccines Pfizer 1/15/21 Lot# EL3248;  Pfizer 2/8/21 Lot# EM9810;  Pfizer 9/27/21 Lot# FC3183;  Pfizer 5/4/22 Lot# FM9992;  Pfizer 10/25/22 Lot# GJ3277
Shortness of breath, hoarseness, wheezing, itchy red eyes, rash on chest, tingling lips, hives near mouth, rapid heartbeat on 1st day, fever on second day.
Client stated she was dizzy shortly after 5th vaccine was administered IM (HPV vaccine was the last one) and then fainted. Fainting lasted less than one minute. Client started speaking and stated she could hear my voice far away and could not see anything. Oxygen applied via mask and client started gaining consciousness and eyesight slowly. After a few minutes, client fully recovered and walked out of office without assistance. Called mother today 4/2 and she stated client did not have problems after they left the office and she has been doing good today.
Pain to Larm at site within 1 hr then unable to lift arm due to severe arm pain nausea, dizzy, felt whole body tingling, blurry vision, body aches
Patient had bruising on arm at site of injection and in a ring around the injection site about 2 to 3 inches across
Tired, muscle aches (especially back pain), fever (101.5), chills, nausea, headache, started at around 8pm, fever broke just after midnight, felt normal by morning.  Took ibuprofen at around 11pm.
pt exp a h/a lasting 4-5 days p/receiving vax; In addition, devel edema & erythema @ the inject site;
A spontaneous report was received from a consumer concerning a 71-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, muscle pain / myalgia, fatigability, been lying on bed the whole afternoon / fatigue, lump / vaccination site mass and redness / vaccination site erythema. The patient's medical history was not provided. Concomitant medications reported were Levothyroxine sodium 0.112mg and Liothyronine sodium 5mcg for drug use for unknown indication. On 22 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 032L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 19 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 023M20A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection. On 20 Feb 2021, the patient had chills, muscle pain, fatiguability and had been lying on bed the whole afternoon. She also had a lump and redness on her right arm which was 2 inches long and 1 and a half inches wide. Treatment details included Tylenol 500mg 2 tabs. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events, chills, muscle pain, fatiguability, been lying on bed the whole afternoon, lump and redness was unknown.
headache; woke up tired; shivering; This case was reported by a consumer via call center representative and described the occurrence of headache in a 69-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (did not have any reactions from the first dose).   On 17th December 2019, the patient received the 2nd dose of Shingrix. On 18th December 2019, 1 days after receiving Shingrix, the patient experienced headache, tiredness and shivering. On an unknown date, the outcome of the headache, tiredness and shivering were not recovered/not resolved.   It was unknown if the reporter considered the headache, tiredness and shivering to be related to Shingrix.  Additional details were provided as follows: The reporter reported that, after vaccination, the patient woke up tired with a headache and shivering. The patient asked, how long the side effects would last. The patient stated that, did not have adverse reaction after 1st dose of Shingrix vaccine.
This spontaneous report as received from a pharmacist refers to a 31 year old post-partum female patient with temporomandibular joint syndrome (TMJ), migraines, sciatica, allergic rhinitis, Gastrooesophageal reflux disease (GERD), endometriosis, exercise induced asthma and TRAMADOL allergy. On 29-JAN-2014 the patient delivery an infant. On 30-JAN-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 lot # J011345, expiration date 11-JAN-2015, 0.5 ml, intramuscular in the left deltoid. On the same day, the patient was also vaccinated with ADACEL (reported also as a concomitant therapy) in the right deltoid. On 30-JAN-2014, the patient experienced sharp pain, swelling from the injection site to the hand, mildly elevated white blood count, numbness and fevers from 101 to 103 (units not provided). Patient experienced pain, significant, that she could not hold infant to breast feed. As the treatment BENADRYL, hydrocodone, acetaminophen and ibuprofen were administered. The pharmacist was unsure if patient would be discharged to home from hospital on 31-JAN-2014 due to fever. The outcome of sharp pain, swelling from the injection site to the hand, mildly elevated white blood count, numbness and fevers and relatedness between therapy and adverse events were not reported. The pharmacist requested lot check. Sharp pain was considered as significant disability by reporting pharmacist. This is one of several report received from the same source. Additional information has been requested.
SITE BECAME RED, HOT ITCHING AND SWOLLEN ON 1/14/2021, 8 DAYS FOLLOWING INJECTION.  THERE WAS SOME MILD SITE SORENESS THE DAY AFTER INJECTION WHICH RESOLVED, UNTIL THE 8TH DAY.
Pt reports redness, warmth, and chills. Onset about 48 hours after administration.  The red area is rather large (about 5"x3")  no fever.
This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 74-year-old female patient who received SHINGRIX. Concurrent medical conditions included blood cholesterol increased (high cholesterol for years) and hematoma (for years and it had not changed). On 22nd February 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 22nd February 2018, less than a day after receiving SHINGRIX, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling and injection site erythema were not recovered/not resolved. The reporter considered the injection site swelling and injection site erythema to be related to SHINGRIX. Additional information was received as follows: Concomitant medication included TRICOR. The patient received SHINGRIX at 03:00, on left deltoid near the hematoma. The patient stated that she did not notice an injection site reaction until later at night after receiving SHINGRIX it was when she felt swelling. The patient said that the injection site was a big red circle, about 2 inches long and 1 and half inches wide. The injection site reaction was raised and swollen above the hematoma. The patient said that the injection site reaction had gotten more red in color in the last 24 hours before the time of reporting. The patient felt fine and she had not experienced other problems.
rash-gen macular papular following #2 dose hep B by 1-2 days;
Left arm swelled. Wheezing and difficulty breathing. Txd with breathing treatment (steroidal) and 1 week course of Benadryl; also administered O2 while in ER.
Immediately after receiving vaccine, 10 seconds nonresponsive, weakness, dizzy.  Rebreathed, fluids rest.
Mild pain around my heart.  Happened after second shot too. I have had pericarditis previously (early 2000's)
Extreme fatigue; chills; achy; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 19Apr2021 at 16:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unspecified date. Concomitant medications included vitamin d nos (VITAMIN D) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. On an unknown date, the patient underwent a COVID-19 virus test and the result was positive COVID-19 test. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 the patient experienced Extreme fatigue, chills, achy. The clinical outcome of the events extreme fatigue, chills, achy was unknown.   No follow-up attempts are needed. No further information is expected.
Information has been received from a certified medical assistant concerning a 17 year old female with no drug reactions/allergies and no report of medical history who on 12-MAR-2007 was vaccinated with the first dose of Gardasil vaccine, 0.5 mL intramuscularly.  There was no concomitant medication. The patient sought medical attention. On 09-MAY-2007, the patient was determined to be 17 weeks pregnant (LMP was 23-JAN-2007). An ultrasound on 09-MAY-2007 was normal. The medical assistant also reported that the patient's pap smear in March 2007 was negative, but a repeat pap smear on 23-May-2007 revealed low grade squamous intraepithelial lesion. Additional information has been requested.  01/07/08 This is in follow-up to report(s) previously submitted on 11/14/2007. Initial and follow-up information has been received from a certified medical assistant concerning a 17 year old female with no drug reactions/allergies and no reported medical history, who on 12-MAR-2007 was vaccinated with the first dose of GARDASIL 0.5 ml intramuscularly. Concomitant therapy included prenatal vitamins. The patient sought medical attention. On 09-MAY-2007 the patient was determined to be 17 weeks pregnant (LMP was 23-JAN-2007). The prenatal vitamins were taken during "all of the pregnancy". An ultrasound on 09-MAY-2007 was normal. The medical assistant also reported that the patient's pap smear in March 2007 was negative, but a repeat pap smear on 23-MAY-2007 revealed low grade squamous intraepithelial lesion. The patient's last menstrual period was 23-JAN-2007 and her estimated delivery date was 30-OCT-2007. The patient did not have any previous pregnancies. On 23-OCT-2007 the patient gave birth to a liveborn female infant. The infant weighed 7 pounds 2 ounces and was 19 1/2 inches long. The infant's apgar score was 8/9. The infant was normal. There were no congenital anomalies, complications, or abnormalities. There were no complications during pregnancy, labor/delivery, no diagnostic tests, and no infections or illnesses during pregnancy. At the time of the report, the outcome of the patient was unknown. Additional information is not expected.
6month term previously healthy female received her 6 month shots on 06/02/09 exactly 12 weeks after her 4month rota vaccine.  On 07/6/09 the patient had an intussusceptive event that was successfully reduced with barium enema. Recovered with no additional events to this date.  7/30/09 Clinic records received DOS 6/2/09 and 7/6/09 Well child visit. Later child presents with bilious vomiting, dehydration. Tired, inactive, lost weight, not crying. Cough, blood in diaper. Sunken anterior fontanelle. Transferred to another facility for surgical consult.   9/9/09 MR received from transfer hospital for DOS 7/6-8/2009 with D/C DX:  Intussusception. Arrived listless and dehydrated with emesis and bloody stools. Reduced by barium enema and d/c after taking po well.  ICD9 560.0  IS.
experienced black eyes; continuous numbness in left arm; continuous migraine; vertigo; This is a spontaneous report from a contactable consumer or other non-HCP. A 30-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EC0142) via an unspecified route of administration, administered in arm left on 13Jan2021 as single dose (at the age of 30-year-old, non-pregnant at the time of vaccination) for COVID-19 immunization. The patient's medical history included arthritis. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK5730) administered in arm left on 22Dec2020 for COVID-19 immunization and experienced no reaction on previous exposure to drug. The patient took albuterol [salbutamol] for product used for unknown indication and experienced drug hypersensitivity. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had not diagnosed with COVID prior vaccination. And post vaccination, patient had not tested with COVID 19. On 01Apr2021, at 15:30 the patient experienced black eyes, continuous numbness in left arm, continuous migraine, vertigo. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 05Apr2021. Therapeutic measures were taken as a result of experienced black eyes, continuous numbness in left arm, continuous migraine, vertigo. The outcome of event was not recovered.
Cellulitis to rt deltoid region measuring 3" X 2". Low grade temperature, Pale.
On February 2,2021 Tuesday around 1030pm I was sitting on the couch I started to cough and then my hands curled up I started shaking, my eyes rolled back and I lost consciousness, after I came to I didn't remember anything. After it happened I couldn't swallow
Patient came to the pharmacy on 10/22/2020 with a rash on both of his arms. It was a red in patches and had some raised pumps. Patient stated it started on Monday night and progressively got worse up to Wednesday. He said it did not get worse or better from Wednesday to Thursday. He stated it was very itchy so I recommended OTC benadryl and hydrocortisone cream. I counseled patient to watch for signs of it getting worse like trouble breathing and the rash spreading and recommended going to an urgent care if it gets worse.
PATIENT DESCRIBED HAVING DIZZINESS, LIGHTHEADEDNESS, BLURRY VISION, AND A DROP IN BP TO 62/32
Tininitus: ringing and muffled hearing experienced on average 2 times per day, lasting about 20 seconds each time.
Pt returned to ED 4 days after receiving Pneumovax 23 c/o flu like symptoms (N/V/chills) and pain 10/10 at injection with blotchy reddened area....cellulitis nodule noted at site of injection. Admit Abx and pain control
She got her vaccine, a couple of weeks after that she started experiencing headaches.  They would last for days at a time and then go away, and come back and stay and go back and forth, and has been experiencing this ever since she got the vaccine.  She is in the process of seeing a new PCP and is scheduled to see one next month.  She has been taking Advil for the headaches, which helps sometimes, and other times it does not.    The headaches have affected her eyes which sometimes get blurry.
Pt came in to complain that she was still experiencing pain in her ar from her flu shot which was administered on 10/31/13. Pt came in on 11/18/13.
Eight days after the injection (1/7/21), I developed an inflamed rash on my left arm. It was hot to the touch and itched .  It was round and approximately 2 inches in diameter.  I called my doctor on 1/8/21, and she had me come in and be seen. She diagnosed as cellulitis from a secondary infection at the injection site and prescribed sulfamethoxazole/Trimethoprim 800/160mg every 13 hours for 7 days. The rash started to go away, but on 1/10/21, it began to itch again and became inflamed. On the morning of 1/11/21, it had grown and changed shape. It is now oval and over 3 inches in diameter. It also has a pronounced border. On, that day, I also found out that 2 co-workers had a similar reaction. I spoke with my doctor, who told me to report it to the CDC.
Approximately 15 minutes after receiving the vaccination, I felt very warm and had a heart rate of around 124. A watch ECG was done and showed PVCs. EMS was brought in, and they took me to the emergency room. I experienced tremors throughout this time. Once I arrived at the hospital, I felt better but still had a heart rate in the 90s. My typical range is 50s-low 60s. Blood sugar was 146, which is high for me. I have no history of diabetes or other blood sugar issues. Blood pressure was taken several times and initially showed 110/66. At the hospital it was 124/72. I was released from the hospital around 1:00 and instructed to come back if symptoms worsened. I had some chest pressure and metallic taste throughout this time.
Stiffness in muscles, joint, severe pain. Cannot raise arms, have difficulty sleeping and dressing.
first dose in left arm couple of days later right hip is in pain all the time, had x-ray on 2/21 and going back to doctor to find out results
Pt States flare  after covid vaccine; This is a spontaneous report from a contactable other hcp (nurse, reported for herself. A 59-years old female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Lot Number and expiration date was not reported), via an unspecified route of administration on an unspecified date as 1st DOSE, SINGLE for covid-19 immunization. The patient also received tofacitinib citrate (XELJANZ XR), oral from Mar2021 (Lot Number: Unknown; Expiration Date: 30Jan2023) to an unspecified date, at 11 mg, daily for rheumatoid arthritis. Medical history included leukocytosis, hypertension, staphylococcal infection, Anaphylaxis from an unknown date, the patient had an unspecified surgery for ankle, also had rheumatoid arthritis from an unknown date. The patient's concomitant medications were not reported. On an unknown date, the patient states flare after covid vaccine. Patient states off medication for 1 week after covid vaccine. The outcome of the event was unknown at the time of report.  No Follow-up attempts are needed. No Information about lot/batch number cannot be obtained.; Sender's Comments: The reported event flare up arthritis is assessed as unrelated to suspected drug BNT162b2 based from known patient's medical history or condition.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
On 4/15/00, face broke out in chicken pox, on 4/16/00, G Measles broke out on stomach and back, on 4/19/00, took her to MD and he said it was a reaction from shots and prescribed Zyrtec for itching. He was also, concerned with yellowing skin. Also, bathed her in Aveeno for 12 days.
had appendicitis & an appendectomy on 23Oct2021; This spontaneous case was reported by a consumer and describes the occurrence of APPENDICITIS (had appendicitis & an appendectomy on 23Oct2021) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced APPENDICITIS (had appendicitis & an appendectomy on 23Oct2021) (seriousness criteria hospitalization and medically significant). The patient was treated with Surgery (Appendectomy) for Appendicitis. At the time of the report, APPENDICITIS (had appendicitis & an appendectomy on 23Oct2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication has been provided.  No treatment medication has been provided.  Company Comment: This spontaneous case concerns a 29-year-old, male patient with no medical history reported, who experienced the unexpected, serious AESI of appendicitis. The event occurred approximately 8 months after administration of the second dose of the Moderna mRNA-1273 vaccine. The patient underwent an Appendectomy on 23Oct2021. No further details were provided. The outcome of the event was unknown at the time of the report. The rechallenge was not applicable as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.; Sender's Comments: This spontaneous case concerns a 29-year-old, male patient with no medical history reported, who experienced the unexpected, serious AESI of appendicitis. The event occurred approximately 8 months after administration of the second dose of the Moderna mRNA-1273 vaccine. The patient underwent an Appendectomy on 23Oct2021. No further details were provided. The outcome of the event was unknown at the time of the report. The rechallenge was not applicable as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.
Vaccines given 0900. Pt presented 5 hours later with warmth and erythema both thighs at sites of inj.
bilateral ring finger swelling, redness Narrative:  Seen in Urgent care, labs sent
Symptoms after vaccine: extremly hot head, sore, and fatigued  A few days after vaccine dose, both ears started a high pitched ringing and have not stopped since. The left ear is louder than the right. There are loud spikes 5-10 days per day where the ringing lasts about 1 mins and it louder than anything going on around me. Doctor diagnosed me with tinnitus. Since the tiitnus started (May 2021) I have has ringing 24/7 sometmes preventing me from sleeping and increased anxiety due to not being able to concenrate.
Patient had fever/chills, nausea, vomiting, followed by a breakthrough seizure.  He missed one dose of his seizure medication due to vomiting.
Pt was given shots on 8/2/01 and 8 hours, post vax, the baby started vomiting, temperature was 101F, he was fussy, and with a bright red, hot and tender lump at Prevnar injection site. Mother gave him Tylenol/ibuprofen. The baby remained not acting himself for 48 hours. Mother calls nurse.